Health ❯ Healthcare ❯ Regulatory Agencies

Anvisa

Drug Approval Process Drug Monitoring Drug Regulations Drug Approval Product Prohibition Drug Prohibition Product Recall Drug Registration Vaccine Approval Pharmacovigilance

Brazil Cracks Down on Illegal GLP-1 Weight‑Loss Injections as Anvisa Tightens Oversight

Regulators say a fast‑growing black market threatens patient safety through sterilization failures, fake inputs and off‑label use.

Fiocruz Flags Rising Influenza A and Severe Respiratory Cases Across Brazil

Anvisa Issues Safety Alert on Misuse of Dermal Fillers in Brazil

Anvisa Logs 65 Suspected Deaths Linked to GLP-1 Weight-Loss Injections in Brazil

Anvisa Issues Safety Alert on GLP‑1 Injection Pens After Six Suspected Pancreatitis Deaths in Brazil

Brazil Approves Twice-Yearly Lenacapavir Injection for HIV Prevention

Brazil Authorizes Leqembi for Early-Stage Alzheimer’s Treatment

Anvisa Orders Lot-Specific Recalls Over Packaging Mix-Ups, Seizes Falsified Drug Batches

Anvisa Bans 30 Landerlan Anabolic Products Over Lack of Registration

Anvisa Orders Recall of Hypofarma Furosemide Batch Over Glass-Like Material